Hormone helps obese shed weight

2012-01-11 18:47
Paris - An appetite-curbing hormone found in the gut may help overweight and obese people shed weight, lower blood pressure and reduce cholesterol levels, according to a study released on Wednesday.

Known as glucagon-like peptide-1, or GLP-1, the hormone is naturally secreted from the intestine when we eat.

Recently, doctors have begun to use GLP-1 to treat patients with type 2 diabetes due to the molecule's ability to regulate sugar levels in the blood.

But they also noticed that the hormone appeared to make patients less hungry, raising the question of whether it could work as a treatment for obesity.

A team of researchers led by Tina Vilsboll of the University of Copenhagen designed a study to find out.

Improvements

Reviewing medical literature, they analysed the results of 25 clinical trials involving over 6 000 patients who had been given GLP-1.

Patients with and without diabetes who received a minimum dosage for at least 20 weeks showed greater weight loss than control groups, they reported in the British Medical Journal (BMJ).

There was also improvement in blood pressure, cholesterol and glycaemic control, the process by which the body adjusts the impact of carbohydrates on blood sugar levels.

The findings provide "convincing evidence" that GLP-1 "results in clinically relevant beneficial effects on body weight" for obese patients, the researchers concluded.

"Additional beneficial effects on blood pressure and total cholesterol might also be achieved."

The treatment had side effects in some patients, including vomiting, nausea and diarrhoea. But this did not seems to effect the number of people dropping out of the trials, suggesting that, overall, GLP-1 was well tolerated, they said.

Vilsboll and colleagues recommended that the hormone be "considered" for obese patients with diabetes, and called for further trials to test its efficacy for obese people who are not diabetic.

In a commentary, also in the BMJ, Raj Padwal from the University of Alberta argued that - despite its weight-reducing powers - GLP-1 should not alter current medical practice.

"Modification of diet and lifestyle remain the cornerstone of the treatment of type 2 diabetes," he said.

The hormone's long-term safety is still unknown, he added.
Read more on:    health  |  research

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
NEXT ON NEWS24X

linking and moving

2015-04-22 07:36

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
4 comments
Comments have been closed for this article.

Inside News24

 
/Sport

Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.